Matches in Nanopublications for { ?s ?p "DDI between Tamsulosin and Nilotinib - Nilotinib, a CYP2D6 inhibitor, may decrease the metabolism and clearance of Tamsulosin, a CYP2D6 substrate. Monitor for changes in therapeutic/adverse effects of Tamsulosin if Nilotinib is initiated, discontinued, or dose changed. [drugbank_resource:DB00706_DB04868]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00706_DB04868 label "DDI between Tamsulosin and Nilotinib - Nilotinib, a CYP2D6 inhibitor, may decrease the metabolism and clearance of Tamsulosin, a CYP2D6 substrate. Monitor for changes in therapeutic/adverse effects of Tamsulosin if Nilotinib is initiated, discontinued, or dose changed. [drugbank_resource:DB00706_DB04868]" assertion.